aid: vedanta-biosciences
name: Vedanta Biosciences
description: 'Vedanta Biosciences is a late clinical-stage biopharmaceutical company
  headquartered at 19 Blackstone Street in Cambridge, Massachusetts, founded by PureTech
  Health together with a group of scientific co-founders who pioneered the modern understanding
  of cross-talk between the human microbiome and the immune system. The company develops
  a potential new category of oral Live Biotherapeutic Products built from rationally
  defined consortia of human commensal bacteria grown from pure clonal cell banks rather
  than donor-derived stool, and it maintains technical expertise in the manufacture of
  live organisms. Its lead program, VE303, is an eight-strain defined bacterial consortium
  in the global Phase 3 RESTORATiVE303 registrational study for the prevention of recurrent
  Clostridioides difficile infection, following Phase 2 results showing a greater than
  80% reduction in the odds of CDI recurrence versus placebo; VE202 is in development
  for inflammatory bowel disease and VE707 for prevention of multidrug-resistant organism
  infections. Vedanta has raised a $68 million Series D and a $106.5 million financing,
  and its programs are supported by non-dilutive awards from BARDA and CARB-X. Vedanta
  is a therapeutics developer, not a software vendor: it runs a WordPress marketing and
  corporate site, publishes no developer portal, no SDKs, no GitHub organization and no
  machine-readable API contract, and an August 2026 probe of vedantabio.com found no
  OpenAPI, no /llms.txt, no MCP endpoint, no A2A agent card and an empty /.well-known/
  discovery surface.'
url: https://raw.githubusercontent.com/api-evangelist/vedanta-biosciences/refs/heads/main/apis.yml
image: https://www.vedantabio.com/wp-content/uploads/2024/12/vedanta-favicon-300x300.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Biotechnology
- Life Sciences
- Pharmaceuticals
- Microbiome
- Live Biotherapeutic Products
- Immunology
- Gastroenterology
- Infectious Disease
- Clinical Research
- Drug Development
- Health Care
- United States
apis: []
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 5
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/vedanta-biosciences-domain-security.yml
- type: Packages
  url: packages/vedanta-biosciences-packages.yml
- type: Conformance
  url: conformance/vedanta-biosciences-conformance.yml
- type: LLMsTxt
  url: llms/vedanta-biosciences-llms.txt
- type: Website
  url: https://www.vedantabio.com/
- type: About
  url: https://www.vedantabio.com/who-we-are/mission/
- type: Leadership
  url: https://www.vedantabio.com/who-we-are/leadership/
- type: Team
  url: https://www.vedantabio.com/who-we-are/team/
- type: Pipeline
  url: https://www.vedantabio.com/pipeline-programs/pipeline/
- type: Science
  url: https://www.vedantabio.com/our-science/defined-bacterial-consortia/
- type: Platform
  url: https://www.vedantabio.com/our-science/product-engine/
- type: Manufacturing
  url: https://www.vedantabio.com/our-science/manufacturing/
- type: IntellectualProperty
  url: https://www.vedantabio.com/our-science/intellectual-property/
- type: Publications
  url: https://www.vedantabio.com/our-science/publications/
- type: Press
  url: https://www.vedantabio.com/our-science/press-releases/
- type: PressRSS
  url: https://www.vedantabio.com/our-science/press-releases/feed/
- type: BlogRSS
  url: https://www.vedantabio.com/feed/
- type: Partners
  url: https://www.vedantabio.com/who-we-are/partnerships/
- type: Careers
  url: https://www.vedantabio.com/who-we-are/open-positions/
- type: Contact
  url: https://www.vedantabio.com/contact/
- type: Support
  url: https://www.vedantabio.com/contact/
- type: TermsOfService
  url: https://www.vedantabio.com/terms-and-conditions/
- type: PrivacyPolicy
  url: https://www.vedantabio.com/privacy-policy/
- type: GitHubOrganization
  url: https://github.com/vedantabio
- type: LinkedIn
  url: https://www.linkedin.com/company/vedanta-biosciences-inc-
- type: Twitter
  url: https://x.com/vedantabio
- type: Crunchbase
  url: https://www.crunchbase.com/organization/vedanta-biosciences
- type: SecondaryMarket
  url: https://forgeglobal.com/vedanta-biosciences_stock/